SymBiosis Capital Management, LLC is a venture capital firm focused on advancing biotherapeutics innovations. Led by Chidozie Ugwumba, Managing Partner, together with an experienced team of professionals, SymBiosis invests across disease area, financing stage, and geography, with a focus on programs in, or about to enter, human trials. SymBiosis has significant, long-term capital commitments to actively support its current portfolio of more than 20 investments and fund future investments.